{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:40:07Z","timestamp":1794051607159,"version":"4.8.0"},"reference-count":24,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T00:00:00Z","timestamp":1425600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Importance<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content> inhibitors have been licensed for the therapy of <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content>\u2010mutated melanoma. Recently, inflammatory skin lesions clinically resembling erythema nodosum have been reported as therapy side\u2010effects that may lead to treatment discontinuation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To identify and characterize cases with <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content> inhibitor\u2010associated erythema nodosum\u2010like inflammatory skin lesions and development of an algorithm for their management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Setting<\/jats:title><jats:p>Retrospective chart review of melanoma patients treated with <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content> inhibitors in 14 departments of Dermatology in Germany and Austria and PubMed search for cases in the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixteen patients were identified who developed erythema nodosum\u2010like lesions under <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content> inhibitor therapy; 14 had received vemurafenib and two dabrafenib plus trametinib. The most frequently involved body sites were the legs. Histopathology was performed in five cases and revealed panniculitis in three and vasculitis in two patients respectively. Arthralgia and fever were associated symptoms in 44% and 31% of patients respectively. Inflammatory symptoms led to discontinuation of treatment in three patients, while in the majority of cases symptomatic management was sufficient. Skin lesions finally resolved despite continued <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content> inhibitor therapy in seven patients. In the literature, 19 additional patients with similar cutaneous appearance under <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content> inhibitors could be identified. An algorithm for the management of such lesions is proposed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Erythema nodosum\u2010like skin lesions histologically correspond to panniculitis and\/or vasculitis. Symptomatic treatment may be sufficient. However, additional work\u2010up and interruption of <jats:styled-content style=\"fixed-case\">BRAF<\/jats:styled-content> inhibitor therapy may be necessary in severe cases which are commonly associated with systemic symptoms.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.13039","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T13:19:42Z","timestamp":1425647982000},"page":"1797-1806","source":"Crossref","is-referenced-by-count":60,"title":["Erythema nodosum\u2010like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature"],"prefix":"10.1111","volume":"29","author":[{"given":"R.","family":"M\u00f6ssner","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology University Medical Center G\u00f6ttingen G\u00f6ttingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Duisburg\u2010Essen Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Berking","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University of Munich (LMU) Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hoeller","sequence":"additional","affiliation":[{"name":"Department of Dermatology Medical University of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Loquai","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Medical Center Mainz Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Richtig","sequence":"additional","affiliation":[{"name":"Department of Dermatology Medical University of Graz Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.C.","family":"K\u00e4hler","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venerology Universit\u00e4tsklinikum Schleswig\u2010Holstein Campus Kiel Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Hassel","sequence":"additional","affiliation":[{"name":"Department of Dermatology and National Center for Tumor Diseases (NCT) University Hospital Heidelberg Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gutzmer","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Skin Cancer Center Hannover Medical School Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ugurel","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of W\u00fcrzburg W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,6]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2013.02.031"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103782"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013513009"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1210093"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.8307"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.05.019"},{"key":"e_1_2_5_8_1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1684\/ejd.2013.1991","article-title":"Vemurafenib\u2010induced panniculitis","volume":"23","author":"Villani AP","year":"2013","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e3283570792"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.2842"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12149"},{"key":"e_1_2_5_12_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1684\/ejd.2012.1915","article-title":"Erythema nodosum in a patient undergoing vemurafenib therapy for metastatic melanoma","volume":"23","author":"Degen A","year":"2013","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_13_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D370X41670","article-title":"Vemurafenib\u2010associated neutrophilic panniculitis: an emergent adverse effect of variable severity","volume":"19","author":"Maldonado\u2010Seral C","year":"2013","journal-title":"Dermatol Online J"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12397"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12316"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70370-6"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-198804000-00006"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12172"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc053425"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2001.01969.x"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2008.01019.x"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02128.x"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08902"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.139"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2258"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13039","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13039","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.13039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T18:12:12Z","timestamp":1695492732000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.13039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,6]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1111\/jdv.13039"],"URL":"https:\/\/doi.org\/10.1111\/jdv.13039","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,6]]}}}